Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/16/22
End: 05/12/23
Due: 05/12/24
Phase: N/A
Priority: Normal
Start: 01/08/22
End: 07/19/23
Due: 07/19/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster | NCT05897190 | Argorna Pharmaceuticals Co., LTD | user2@example.com | None | 2022-05-16 | 2023-05-12 | 2024-05-12 | - | - | 2025-07-14 |
| A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults | NCT05903118 | Argorna Pharmaceuticals Co., LTD | user2@example.com | None | 2022-01-08 | 2023-07-19 | 2024-07-19 | - | - | 2025-07-14 |